LEUVEN, Belgium, Dec. 5, 2013 (GLOBE NEWSWIRE) -- TiGenix (Euronext Brussels: TIG) announced today that it has appointed Dirk Büscher and José Terencio to the Company's board of directors, in replacement of Nico Vandervelpen (LRM Beheer NV) and Joël Jean-Mairet (Ysios Capital Partners SGEGR SA), who resigned from the board. The appointments follow the recent EUR 12 million investment by Gri-Cel SA in TiGenix. Gri-Cel is a fully-owned subsidiary of Grifols, a world leader in plasma-derived therapeutics.
Help employers find you! Check out all the jobs and post your resume.
